Obesity is typically assessed by measuring someone's body mass index, but now researchers are calling for a more nuanced ...

Novo Nordisk said a higher dose of its drug Wegovy led to greater weight loss in patients during a late-stage trial, but the ...

By coincidence (they started before GLP -1 drugs were approved for slimming), a group of 56 doctors have just answered that ...

A new report says only using BMI to determine if a patient has obesity leads to under-diagnosing people who are ill and ...

Ozempic and Wegovy, the blockbuster but costly GLP-1 drugs often used for weight loss, are among the 15 medications that will ...

Officer of Protagonist Therapeutics, Inc. (NASDAQ:PTGX), a $2.2 billion market cap biotech company, recently reported the sale of 3,640 shares of common stock on January 16, 2025. The transactions ...

When it comes to weight loss drugs, Ozempic has become a phenomenon. With nearly $14 billion in sales in 2023, it shows no ...

Stock prices for Novo Nordisk fell by about 3% at market open after the Biden administration selected its revolutionary drugs ...